An example of a Tier 1 abnormality is NUP98 rearrangement in AML—a class-defining cytogenetics alteration—where detection of NUP98-R qualifies patients for treatment with menin inhibitors. This evidence concerns the gene MEN1 and acute myeloid leukemia.